Tarsus Pharmaceuticals, Inc. (TARS) Financials

TARS Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 581.1 million 232.2 million
Dec. 31, 2025 562.2 million 218.7 million
Sept. 30, 2025 534.6 million 199.5 million
June 30, 2025 495.0 million 162.4 million

TARS Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -30.5 million 12.0 million
Dec. 31, 2025 13.0 million 14.3 million
Sept. 30, 2025 16.3 million 12.2 million
June 30, 2025 -30.4 million 8.2 million

TARS Net Income

No data available :(

TARS Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 388.7 million 72.6 million 16.1 million
Dec. 31, 2025 417.3 million 83.0 million 10.6 million
Sept. 30, 2025 401.8 million 72.3 million 10.1 million
June 30, 2025 381.1 million 72.1 million 317000

TARS Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 43.0 million
Dec. 31, 2025 42.8 million
Sept. 30, 2025 42.6 million
June 30, 2025 42.4 million

TARS Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 5.8 million 22.4 million 136.4 million -
Dec. 31, 2025 6.4 million 18.0 million 130.7 million -
Sept. 30, 2025 1.9 million 16.3 million 108.6 million -
June 30, 2025 1.0 million 15.6 million 103.0 million -

TARS Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 162.1 million 9.4 million
Dec. 31, 2025 151.7 million 10.9 million
Sept. 30, 2025 118.7 million 24.6 million
June 30, 2025 102.7 million 6.2 million

TARS Revenue by Segment
Graph available only for paid members. Upgrade to see it.

TARS

Price: $61.85

52 week price:
38.51
85.25

Earnings Per Share: -1.11 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 37491

Market Capitalization: 2.5 billion

Links: